Patent: 5,082,642
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,082,642
| Title: | Method for catalyzing oxidation/reduction reactions of simple molecules |
| Abstract: | This invention relates to a method for catalyzing the reactions wherein Q=C or N; Z=O or S; X=O, S, NH or NR; R=C.sub.1 to C.sub.8 alkyl which may be linear, branched or cyclized, which comprises: contacting at least one polydentate nitrogen-containing chelating agent complexed with a metal atom with the reactants of one of said reactions, wherein said contacting takes place in the presence of a means for oxidizing when reaction (1) is catalyzed and in the presence of a means for reducing when reaction (2) is catalyzed. A particular reaction is the conversion of NO to NO.sub.2 using water and supported porphines, hemes, phthalocyanines, ethioporphrins sirohemes, particularly heme and heme compounds or derivatives such as methemoglobin, myoglobin, or hemin. |
| Inventor(s): | Bickar; David (Baltimore, MD), Bonaventura; Celia (Beaufort, NC), Bonaventura; Joseph (Beaufort, NC) |
| Assignee: | Duke University (Durham, NC) |
| Application Number: | 07/607,634 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,082,642
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | PANHEMATIN | hemin for injection | For Injection | 101246 | 07/20/1983 | See Plans and Pricing | 2009-01-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
